STOM
Aliases:
This biomarker is also known as:- EPB7
- erythrocyte band 7 integral membrane protein
- protein 7.2b
- stomatin
- EPB72
- erythrocyte surface protein band 7.2
- erythrocyte membrane protein band 7.2 (stomatin)
- STOM
- BND7
- Protein 7.2b
- Stomatin
Description…
STOM, or stomatin, is an integral membrane protein located in the cell membrane of red blood cells and other cell types, where it is thought to regulate ion channels and transporters. Multiple transcript variants are produced by alternative splicing.
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| Type: | Gene |
| HGNC Name: | STOM |
The following organs have data associated with this biomarker…
Attributes
| Phase: | 2 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Attributes
| Phase: | 1 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- Multianalyte tests for the early detection of cancer: speedbumps and barriers.
- History and molecular genetics of Lynch syndrome in family G: a century later.
- Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
- Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
- TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
- Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis.